The CF carrier status is not associated with a diminished self-concept or increased anxiety: Results of psychometric testing after at least 1 year

Clinical Genetics

Volumn 49, Issue 5, 1996, Pages 232-236

  Denayer, Lieve ^a   Welkenhuysen, Myriam ^a   Evers Kiebooms, Gerry ^a,b   Cassiman, Jean Jacques ^a   Van Den Berghe, Herman ^a  

^a CENTER FOR HUMAN GENETICS   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cystic fibrosis; Heterozygote detection; Psychology; Social adaptation

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FAMILY; FEMALE; GENETIC COUNSELING; HETEROZYGOTE DETECTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; RELATIVE; SELF CONCEPT; SIBLING; STATISTICAL ANALYSIS;

EID: 0029901198     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1996.tb03779.x     Document Type: Article

References (15)

1. Bekker H, Denniss G, Modell M, Bobrow M, Marteau T. The impact of population-based screening for carriers of cystic fibrosis. J Med Genet 1994: 31: 364-368.
2. Childs B, Gordis L, Kaback M, Kazazian HH. Tay-Sachs screening: social and psychological impact. Am J Hum Genet 1976: 28: 550-558.
3. Clow CL, Scriver CR. Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience. Pediatrics 1977: 59: 86-91.
4. Evers-Kiebooms G, Denayer L, Welkenhuysen M, Cassiman JJ, Van den Berghe H. A stigmatizing effect of the carrier status for cystic fibrosis? Clin Genet 1994: 46: 336-343.
5. Fanos JH, Nickerson BG. Long-term effects of sibling death during adolescence. J Adol Res 1991: 6: 70-82.
6. Fitts WH. Tennessee Self-Concept Scale Manual. Nashville, Tennessee: Counselor recordings and tests, 1965.
7. Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989: 245: 1073-1080.
8. Marteau TM, Van Duijn M, Ellis I. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet 1992: 29: 24-26.
9. Mennie ME, Compton M, Gilfillan A, Liston WA, Pullen I, Whyte DA, Brock DJH. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet 1993: 30: 543-548.
10. Rowley PT, Lipkin MJ, Fisher L. Screening and genetic counseling for Beta-Thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet 1984: 36: 677-689.
11. The American Society of Human Genetics. Statement on cystic fibrosis carrier screening. Am J Hum Genet 1992: 51: 1443-1444.
12. Van der Ploeg HM, Defares PB, Spielberger CD. Handleiding bij de zelf-beoordelings vragenlijst ZBV. Een nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Lisse: Zwets & Zeitlinger B.V., 1980.
13. Watson EK, Mayall ES, Lamb J, Chapple J, Williamson R. Psychological and social consequences of a community carrier screening programme for cystic fibrosis. Lancet 1992: 340: 217-220.
14. Wooldridge EQ, Murray RF. The Health Orientation Scale: a measure of feelings about sickle cell trait. Social Biology 1989: 35: 123-136.
15. Zeesman S, Clow CL, Cartier L, Scriver CR. A private view of heterozygosity: 8-year follow-up on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet 1984: 18: 769-778.